NORDIC PROTEINFINGERPRINT TECHNOLOGY
DEAD

Serial Number

79386701

Owner

Nordic Bioscience A/S

Attorney

Bradley M. Stohry

Filing Date

Sep 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NORDIC PROTEINFINGERPRINT TECHNOLOGY Trademark

Serial Number: 79386701

NORDIC PROTEINFINGERPRINT TECHNOLOGY is a trademark filed by Nordic Bioscience A/S on September 19, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Nordic Bioscience A/S (10 trademarks)

Herlev Hovedgade 205-207

Entity Type: 99

Trademark Details

Filing Date

September 19, 2023

Registration Date

Not Registered

Goods & Services

Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis for medical and pharmaceutical research services; advice, information and assistance relating to the foregoing

Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 11, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Nov 25, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 25, 2025 FICR
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 4, 2025 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jul 4, 2025 DETH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 27, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 3, 2025 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 25, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 25, 2024 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 9, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 9, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 9, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 9, 2024 COAR
REFUSAL PROCESSED BY IB
May 28, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 9, 2024 RFCS
REFUSAL PROCESSED BY MPU
May 9, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 3, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 2, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 9, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 4, 2024 REPR